🇰🇷 South Korea Country × Condition
atrial fibrillation Clinical Trials in South Korea
Active clinical trials for atrial fibrillation with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 4 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT05794386
Recruiting
SCAR Burden of Left Atrium Guided cathEter Ablation sTrategy for Persistent Atrial Fibrillation
Enrollment
204 pts
Country
🇰🇷 South Korea
Seoul National University Hospital
View Trial → NCT06187311 Phase 4
Recruiting
Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation
Enrollment
940 pts
Country
🇰🇷 South Korea
Korea University Anam Hospital
View Trial → Frequently Asked Questions
How many atrial fibrillation clinical trials are active in South Korea?
There are currently 2 active clinical trials for atrial fibrillation with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a atrial fibrillation clinical trial in South Korea?
To join a atrial fibrillation clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are atrial fibrillation trials in South Korea?
Active atrial fibrillation trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology